The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3)

EDITORIAL  RAI THERAPY IN ADVANCED DIFFERENTIATED THYROID CANCER: FOCUS ON DOSIMETRY

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):227-8

Radioiodine dosimetry in advanced thyroid cancer

Luca GIOVANELLA *, Michael LASSMANN

HTML PDF

REVIEW  RAI THERAPY IN ADVANCED DIFFERENTIATED THYROID CANCER: FOCUS ON DOSIMETRY

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):229-34

Radioiodine therapy of advanced differentiated thyroid cancer: clinical considerations and multidisciplinary approach

Luca GIOVANELLA *, Lorenzo SCAPPATICCIO

Abstract HTML PDF

REVIEW  RAI THERAPY IN ADVANCED DIFFERENTIATED THYROID CANCER: FOCUS ON DOSIMETRY

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):235-52

The role of 124I PET/CT lesion dosimetry in differentiated thyroid cancer

Manuel WEBER, Ina BINSE, James NAGARAJAH, Andreas BOCKISCH, Ken HERRMANN, Walter JENTZEN *

Abstract HTML PDF

REVIEW  RAI THERAPY IN ADVANCED DIFFERENTIATED THYROID CANCER: FOCUS ON DOSIMETRYFree access

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):253-7

Advantages of dosimetry in 131I therapy of differentiated thyroid carcinoma

Frederik A. VERBURG *

Abstract HTML PDF

REVIEW  RAI THERAPY IN ADVANCED DIFFERENTIATED THYROID CANCER: FOCUS ON DOSIMETRYFree access

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):258-66

Major limits of dosimetrically determined activities in advanced differentiated thyroid carcinoma

Monica FINESSI *, Virginia LIBERINI, Désirée DEANDREIS

Abstract HTML PDF

REVIEW  RAI THERAPY IN ADVANCED DIFFERENTIATED THYROID CANCER: FOCUS ON DOSIMETRY

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):267-70

Advanced differentiated thyroid cancer: when to stop radioiodine?

Luca GIOVANELLA *, Douglas van NOSTRAND

Abstract HTML PDF

REVIEW  RAI THERAPY IN ADVANCED DIFFERENTIATED THYROID CANCER: FOCUS ON DOSIMETRYFree access

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):271-7

Physics aspects of setting up a multicenter clinical trial involving internal dosimetry of radioiodine treatment of differentiated thyroid cancer

Jan TAPROGGE *, Francesca LEEK, Glenn D. FLUX

Abstract HTML PDF

ORIGINAL ARTICLE  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):278-83

The effects of androgen deprivation therapy on the 18F-Chcoline uptake in prostate cancer patients undergoing neoadjuvant treatment

Laura EVANGELISTA *, Fabio ZATTONI, Andrea GUTTILLA, Umberto BASSO, Filiberto ZATTONI

Abstract PDF

ORIGINAL ARTICLE  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):284-91

Evaluation of 2 diuretic 18fluorine-fluorodeoxyglucose positron emission tomography/computed tomography imaging protocols for intrapelvic cancer

Lawrence O. DIERICKX *, Laurent DERCLE, Leonor CHALTIEL, Olivier CASELLES, Séverine BRILLOUET, Slimane ZERDOUD, Frédéric COURBON

Abstract HTML PDF

ORIGINAL ARTICLE  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):292-301

Breath-hold [68Ga]DOTA-TOC PET/CT in neuroendocrine tumors: detection of additional lesions and effects on quantitative parameters

Mariana ZIRNSAK, Robert BÄRWOLF, Martin FREESMEYER *

Abstract HTML PDF

ORIGINAL ARTICLE  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):302-10

Physical training improves myocardial perfusion but not left ventricular function response to exercise in patients with microvascular angina

Eduardo E. CARVALHO, Júlio C. CRESCÊNCIO, Giovani L. SANTI, Luciano F. OLIVEIRA, Pedro V. SCHWARTZMANN, Lourenço GALLO-JUNIOR, José A. MARIN-NETO, Marcus V. SIMÕES *

Abstract HTML PDF

ORIGINAL ARTICLE  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):311-20

Diffusion-weighted MRI is not superior to FDG-PET/CT for the detection of neck recurrence in well-differentiated thyroid carcinoma

Pierre VERA *, Agathe EDET-SANSON, Farzaneh QUIEFFIN, Joseph LE CLOIREC, Anne-Sophie BERTRAND, Martin CAILLEAUX, Jean-Francois MENARD, Charlotte LUSSEY-LEPOUTRE, Francoise CALLONNEC

Abstract PDF